Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 4, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 4, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 3, 2021 3

Initial filing by director officer or owner of more than ten percent.

View HTML
November 3, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
November 1, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 1, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
September 28, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 9, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
August 24, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us